论文信息 - U.S. Intergroup phase II trial (SWOG 1108) of alisertib, an investigational aurora A kinase (AAK) inhibitor, in patients with peripheral T-cell lymphoma (PTCL; NCT01466881). - 字舞流文

U.S. Intergroup phase II trial (SWOG 1108) of alisertib, an investigational aurora A kinase (AAK) inhibitor, in patients with peripheral T-cell lymphoma (PTCL; NCT01466881).

J. Friedberg | C. Flowers | R. Fisher | B. Cheson | T. Miller | S. Horwitz | D. Mahadevan | P. Barr | N. Wagner-Johnston | M. M. Haq | C. Spier | Hongli Li | M. LeBlanc